In the U.S. over 500,000 shoulder and Achilles tendon repair procedures are performed every year, representing a considerable fraction of the sports injuries market. One significant complication with tendon repair is the incidence of re-tearing operated injuries. It is estimated that reinforcement and augmentation products are presently utilized in roughly 1 in 10 shoulder and 3 in 10 Achilles tendon repair procedures. The current market for these products is expanding rapidly, specifically for biological products which are expected to see strong growth driven by increasing demand. In addition, product innovation will be paramount to enhancing the performance and safety of the devices as well as adding variety to existing product selections. Finally, strong demand is expected to persist as product visibility and adoption continues.